2m 2m 2m 2m 2m 2m 2m
CELLDEX THERAPTC (CLDX)
NASDAQ
$36.90-$0.005 (-0.01%)
Price as of Sep 11, 2026 7:30 PM EDT- $2.9BMarket Cap
- 50.92%1-Year Change
- BiotechnologyIndustry
CELLDEX THERAPTC (CLDX)
$36.90-$0.005 (-0.01%)
CLDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $36.90 | ||
Change | -$1.20 (-3.15%) | ||
Open | $38.39 | ||
High | $38.59 | ||
Low | $36.84 | ||
Previous Close | $38.10 | ||
Volume | 1,033,541 | ||
30-Day Average Volume | 741,309 | ||
1-Week Change | -7.01% | ||
1-Month Change | -16.76% | ||
1-Year Change | 50.92% | ||
3-Year Change | 34.04% | ||
5-Year Change | -32.32% | ||
Fundamentals | |||
Shares Outstanding | 78.5M | ||
Total Assets | $782.3M | ||
Market Cap | $2.9B | ||
Enterprise Value | $2.9B | ||
Period: QTR TTM FY | |||
Revenue | $7,000.00 | ||
Net Income | -$73.5M | ||
Free Cash Flow | -$60.6M | ||
EBIT | -$73.5M | ||
EBITDA | -$72.6M | ||
Net Working Capital | $663.6M | ||
EPS | -$0.94 | ||
Enterprise Value/EBITDA | -39 | ||
Enterprise Value/Revenue | 407,184 | ||
P/B | 4 | ||
P/E | -39 | ||
PEG | -2 | ||
Price/Free Cash Flow | -48 | ||
Price/Operating Cash Flow | -50 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 02/11/2019 | ||
Earnings & Revenue